Neurocrine Biosciences Shares Outstanding 2006-2020 | NBIX

Neurocrine Biosciences shares outstanding history from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Neurocrine Biosciences shares outstanding for the quarter ending March 31, 2020 were 0.097B, a 6.48% increase year-over-year.
  • Neurocrine Biosciences 2019 shares outstanding were 0.096B, a 0.36% increase from 2018.
  • Neurocrine Biosciences 2018 shares outstanding were 0.095B, a 8.28% increase from 2017.
  • Neurocrine Biosciences 2017 shares outstanding were 0.088B, a 1.59% increase from 2016.
Neurocrine Biosciences Annual Shares Outstanding
(Millions of Shares)
2019 96
2018 95
2017 88
2016 87
2015 84
2014 75
2013 67
2012 67
2011 56
2010 53
2009 39
2008 38
2007 38
2006 38
2005 37
Neurocrine Biosciences Quarterly Shares Outstanding
(Millions of Shares)
2020-03-31 97
2019-12-31 96
2019-09-30 96
2019-06-30 95
2019-03-31 91
2018-12-31 95
2018-09-30 97
2018-06-30 90
2018-03-31 90
2017-12-31 88
2017-09-30 88
2017-06-30 88
2017-03-31 87
2016-12-31 87
2016-09-30 87
2016-06-30 87
2016-03-31 86
2015-12-31 84
2015-09-30 86
2015-06-30 86
2015-03-31 80
2014-12-31 75
2014-09-30 76
2014-06-30 76
2014-03-31 70
2013-12-31 67
2013-09-30 67
2013-06-30 67
2013-03-31 67
2012-12-31 67
2012-09-30 66
2012-06-30 66
2012-03-31 63
2011-12-31 56
2011-09-30 56
2011-06-30 56
2011-03-31 56
2010-12-31 53
2010-09-30 56
2010-06-30 55
2010-03-31 47
2009-12-31 39
2009-09-30 39
2009-06-30 39
2009-03-31 39
2008-12-31 38
2008-09-30 38
2008-06-30 38
2008-03-31 38
2007-12-31 38
2007-09-30 38
2007-06-30 38
2007-03-31 38
2006-12-31 38
2006-09-30 38
2006-06-30 38
2006-03-31 37
2005-12-31 37
2005-09-30 38
2005-06-30 37
2005-03-31 37
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $11.330B $0.788B
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.086B 36.94
Takeda Pharmaceutical (TAK) Japan $56.529B 9.91
Astellas Pharma (ALPMY) Japan $31.017B 15.72
Eisai (ESALY) Japan $23.530B 20.40
UCB SA (UCBJF) Belgium $22.485B 0.00
Merck (MKGAF) Germany $14.895B 19.53
Grifols, S.A (GRFS) Spain $12.541B 15.59
Catalent (CTLT) United States $11.354B 43.89
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Ionis Pharmaceuticals (IONS) United States $8.214B 43.67
IPSEN SA ADR (IPSEY) France $6.994B 0.00
Orion OYJ (ORINY) Finland $6.766B 30.32
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.107B 9.77
United Therapeutics (UTHR) United States $5.325B 10.09
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.396B 479.89
Nektar Therapeutics (NKTR) United States $4.122B 0.00
Evotec AG (EVTCY) Germany $4.062B 109.59
Hypermarcas (HYPMY) Brazil $3.800B 11.56
FibroGen (FGEN) United States $3.611B 0.00
ChemoCentryx (CCXI) United States $3.559B 0.00
PTC Therapeutics (PTCT) United States $3.322B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.544B 10.45
Pacira BioSciences (PCRX) United States $2.210B 45.23
Sage Therapeutics (SAGE) United States $2.159B 0.00
Cronos Group (CRON) Canada $2.097B 60.10
Corcept Therapeutics (CORT) United States $1.928B 19.11
Indivior (INVVY) United States $1.904B 23.64
Xencor (XNCR) United States $1.846B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.830B 0.00
Akebia Therapeutics (AKBA) United States $1.769B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.645B 12.59
USANA Health Sciences (USNA) United States $1.543B 15.82
Zogenix (ZGNX) United States $1.495B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.425B 15.35
Esperion Therapeutics (ESPR) United States $1.417B 0.00
Portola Pharmaceuticals (PTLA) United States $1.412B 0.00
Karyopharm Therapeutics (KPTI) United States $1.385B 0.00
Heron Therapeutics (HRTX) United States $1.333B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.324B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.250B 0.00
Translate Bio (TBIO) United States $1.127B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.004B 44.83
Tilray (TLRY) Canada $0.888B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.841B 0.00
ImmunoGen (IMGN) United States $0.802B 0.00
Endo (ENDP) Ireland $0.788B 1.22
Aerie Pharmaceuticals (AERI) United States $0.686B 0.00
Trillium Therapeutics (TRIL) Canada $0.675B 0.00
VAXART, INC (VXRT) United States $0.657B 0.00
Radius Health (RDUS) United States $0.632B 0.00
Molecular Templates (MTEM) United States $0.631B 0.00
Ardelyx (ARDX) United States $0.615B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.608B 0.00
Collegium Pharmaceutical (COLL) United States $0.601B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.575B 0.00
Flexion Therapeutics (FLXN) United States $0.507B 0.00
Siga Technologies (SIGA) United States $0.479B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.478B 11.55
Innate Pharma SA (IPHYF) France $0.476B 0.00
DURECT (DRRX) United States $0.455B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.450B 17.56
Ocular Therapeutix (OCUL) United States $0.445B 0.00
MEI Pharma (MEIP) United States $0.438B 0.00
Harpoon Therapeutics (HARP) United States $0.415B 0.00
Organogenesis Holdings (ORGO) United States $0.407B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.394B 0.00
Calithera Biosciences (CALA) United States $0.372B 0.00
OptiNose (OPTN) United States $0.342B 0.00
TherapeuticsMD (TXMD) United States $0.340B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.308B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.303B 0.00
Concert Pharmaceuticals (CNCE) United States $0.295B 0.00
Lannett Co Inc (LCI) United States $0.293B 6.42
PROFOUND MEDICL (PROF) Canada $0.272B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.262B 0.00
CASI Pharmaceuticals (CASI) United States $0.252B 0.00
Redhill Biopharma (RDHL) Israel $0.236B 0.00
Jounce Therapeutics (JNCE) United States $0.235B 5.61
Rafael Holdings (RFL) United States $0.227B 0.00
Taiwan Liposome (TLC) Taiwan $0.225B 0.00
KalVista Pharmaceuticals (KALV) United States $0.216B 0.00
IMV INC (IMV) Canada $0.190B 0.00
Nivalis Therapeutics (ALPN) United States $0.180B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 23.10
Altimmune (ALT) United States $0.166B 0.00
Aquestive Therapeutics (AQST) United States $0.163B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.153B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.116B 0.00
Champions Oncology (CSBR) United States $0.114B 0.00
Otonomy (OTIC) United States $0.112B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.110B 0.00
Recro Pharma (REPH) United States $0.107B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.106B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.101B 0.00
Xeris Pharmaceuticals (XERS) United States $0.100B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.098B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.096B 0.00
Onconova Therapeutics (ONTX) United States $0.095B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.095B 0.00
Sundial Growers (SNDL) Canada $0.086B 0.00
CTI BioPharma (CTIC) United States $0.085B 0.00
Hemispherx BioPharma (AIM) United States $0.081B 0.00
MediWound (MDWD) Israel $0.081B 0.00
SCYNEXIS (SCYX) United States $0.074B 0.00
Biomerica (BMRA) United States $0.072B 0.00
Heat Biologics (HTBX) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.070B 0.00
Aclaris Therapeutics (ACRS) United States $0.068B 0.00
CV Sciences (CVSI) United States $0.062B 0.00
Lipocine (LPCN) United States $0.060B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.27
Addex Therapeutics (ADXN) Switzerland $0.048B 0.00
PolarityTE (PTE) United States $0.048B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
GTx (ONCT) United States $0.044B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.038B 82.09
Novan (NOVN) United States $0.038B 0.00
IsoRay (ISR) United States $0.038B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.038B 0.00
AgeX Therapeutics (AGE) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.035B 6.70
Neos Therapeutics (NEOS) United States $0.034B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.033B 0.00
ElectroCore (ECOR) United States $0.031B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Jaguar Animal Health (JAGX) United States $0.029B 0.00
India Globalization Capital (IGC) United States $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.018B 0.00
Can-Fite Biopharma (CANF) Israel $0.017B 0.00
Iterum Therapeutics (ITRM) Ireland $0.017B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Shineco (TYHT) China $0.015B 0.00
China SXT Pharmaceuticals (SXTC) China $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 33.29
Sonoma Pharmaceuticals (SNOA) United States $0.013B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
Vical (BBI) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00